SCHEMBL874767

SCHEMBL874767

O=C(O)[C@H](Cc1ccc(O)cc1I)N(I)I

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PCNA P12004 1/20 0.36
▸ KMT2A Q03164 3/20 0.35
▸ CYP3A4 P08684 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ HTR1A P08908 1/20 0.35
▸ ADORA3 P0DMS8 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ NFKB1 P19838 1/20 0.35
▸ HTR2A P28223 1/20 0.35
▸ HTR2C P28335 1/20 0.35
▸ SLC6A4 P31645 1/20 0.35
▸ HTR7 P34969 1/20 0.35
▸ HTR2B P41595 1/20 0.35
▸ MTOR P42345 1/20 0.35
▸ BLM P54132 1/20 0.35
▸ PMP22 Q01453 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1133432 1.00 PCNA (0.36) PCNAKMT2ACYP3A4KDM4EALDH1A1
SCHEMBL22468340 0.98 PCNA (0.35) PCNAKMT2ACYP3A4KDM4EALDH1A1
SCHEMBL9522866 0.85 PCNA (0.36) PCNAKMT2ACYP3A4KDM4EALDH1A1
SCHEMBL9522476 0.83 PCNA (0.37) PCNAKMT2ACYP3A4ALDH1A1LMNA
SCHEMBL4954960 0.79 MTNR1A (0.35) PCNASLC7A5
SCHEMBL11356756 0.77 KDM6B (0.33) KMT2ACYP3A4KDM4EALDH1A1LMNA
SCHEMBL31189933 0.77 KDM4E (0.56) PCNAKMT2ACYP3A4KDM4EALDH1A1
SCHEMBL1572564 0.77 KDM4E (0.56) PCNAKMT2ACYP3A4KDM4EALDH1A1
SCHEMBL1572565 0.77 KDM4E (0.56) PCNAKMT2ACYP3A4KDM4EALDH1A1
SCHEMBL169322 0.76 SLC7A5 (0.55) SLC7A5CAMK2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120077268-A1 ANIMAL-FREE CELL CULTURE METHOD GLAXOSMITHKLINE BIOLOGICALS, S.A. (BE) 2012-03-29 — — US claimed
US-20120077268-A1 ANIMAL-FREE CELL CULTURE METHOD GLAXOSMITHKLINE BIOLOGICALS, S.A. (BE) 2012-03-29 — — US disclosed
US-8034617-B2 Cell culture in culture media free of components of animal origin GLAXOSMITHKLINE BIOLOGICALS S.A. (BE) 2011-10-11 — — US disclosed
EP-2192175-A1 Animal-free cell culture method GlaxoSmithKline Biologicals S.A. (BE) 2010-06-02 — — EP disclosed
EP-2186885-A1 Animal-free cell culture method GlaxoSmithKline Biologicals S.A. (BE) 2010-05-19 — — EP disclosed
US-20060183224-A1 Animal-free cell culture method GLAXOSMITHKLINE BIOLOGICALS, S.A. (BE) 2006-08-17 — — US disclosed
EP-1599580-A1 ANIMAL-FREE CELL CULTURE METHOD GlaxoSmithKline Biologicals S.A. (BE) 2005-11-30 — — EP disclosed
WO-2004078955-A1 ANIMAL-FREE CELL CULTURE METHOD GLAXOSMITHKLINE BIOLOGICALS S.A. (BE) 2004-09-16 — — WO disclosed
Send feedback